Lenalidomide can reduce the proliferation of astrocyte, microglia and the level of α-syn by inhibiting the production of TNF-α in MSA mice, and the effect of lenalidomide can partially improve the motor dysfunction of MSA mice (Valera et al., 2017). The gene discussed is TNF; the disease is multiple system atrophy.